In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.

Researchers have bioprinted human islets designed to mimic the body’s own tissue structure, allowing them to integrate ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

A global research team, led by Wake Forest University’s Dr. Quentin Perrier, has successfully 3D-printed functioning human ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

By Nancy Lapid (Reuters) -Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

Insulin therapy for Type 2 diabetes. Diabetes is a condition in which your pancreas fails to secrete a sufficient amount of insulin to help you to maintain normal blood glucose, or sugar in the ...

Intensive insulin therapy reduced the cumulative TISS-28 scores among patients in the ICU by 20 percent (454±22 in the conventional-treatment group vs. 388±17 in the intensive-treatment group, ...